SBI Securities’s iBio IBIO Stock Holding History

SBI Securities’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74	Buy	42 +20	+91%	+$36	﹤0.01%	3582
2026 Q1	$42	Hold	22	–	–	﹤0.01%	3613
2025 Q4	$42	Hold	22	–	–	﹤0.01%	3612
2025 Q3	$18	Sell	22 -201	-90%	-$154	﹤0.01%	3932
2025 Q2	$170	Sell	223 -177	-44%	-$192	﹤0.01%	3368
2025 Q1	$1.61K	Buy	400 +133	+50%	+$517	﹤0.01%	2384
2024 Q4	$654	Buy	+267	New	+$686	﹤0.01%	2794

Other funds holding IBIO

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

NCM

Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return

IAAG

Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SWA

SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

FGC

Financial Gravity Companies Lakeway, Texas $616M AUM

SBI Securities's IBIO Position: Q2 2026 in Review

SBI Securities increased its iBio (IBIO) stake by 91% in Q2 2026, buying an estimated $36 and bringing the position to 42 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

SBI Securities first reported a position in IBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.61K in Q1 2025. 10 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

SBI Securities held 42 shares of iBio worth $74 as of Q2 2026.
SBI Securities bought 20 iBio shares in Q2 2026, an estimated $36.
iBio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3582 holding.
SBI Securities first reported a position in iBio in Q4 2024 and has held it in 7 quarters since.
SBI Securities's iBio position peaked at $1.61K in Q1 2025.
10 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.